Eleison Pharmaceuticals Overview
- Founded
-
2009
- Status
-
IPO Registration
- Employees
-
2
- Latest Deal Type
-
IPO
- (Announced)
- Financing Rounds
-
4
Eleison Pharmaceuticals General Information
Description
Developer of specialty pharmaceuticals and life-saving drugs for cancer treatment. The company acquires, develops and commercializes clinical-stage drug therapies for lung, pancreatic, brain and other types of cancers, thus providing patients with a new hope to fight these rare and life-threatening diseases.
Contact Information
Website
www.eleison-pharma.com
Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 100 Overlook Center
- 2nd Floor
- Princeton, NJ 08540
- United States
+1 (215) 000-0000
Eleison Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eleison Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of specialty pharmaceuticals and life-saving drugs for cancer treatment. The company acquires, develops and co
Drug Discovery
Princeton, NJ
2
As of 2022
0000
00000000
0000
000000
ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000 000000000
Bethesda, MD
00
As of 0000
00000
000000000 -
00000
000000
bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
Burlington, MA
00
As of 0000
00000
0000000000 0
00000
Add Comparison
Eleison Pharmaceuticals Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Northwest Biotherapeutics | Corporation | Bethesda, MD | 00 | 00000 | 000000000 - | 00000 |
| 000000000 000000 | Venture Capital-Backed | Burlington, MA | 00 | 00000 | 0000000000 0 | 00000 |
| 000000 00000000000 | Formerly VC-backed | Needham, MA | 00 | 00000 | 00000000 | 00000 |
| 0000 00000000 | Formerly VC-backed | Stamford, CT | 00 | 00000 | 000000&0 | 00000 |
| 0000000 000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 000.00 | 0000000000 0 | 000.00 |
Eleison Pharmaceuticals Patents
Eleison Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020262112-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | 0000000000 | |
| CA-3137952-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | 0000000000 | |
| EP-3958848-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | 0000000000 | |
| JP-2022529990-A | Combination treatment regimen with 1,6-dibromo-1,6-dideoxy-zlucitol | Pending | 24-Apr-2019 | 0000000000 | |
| US-20220142941-A1 | Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol | Pending | 24-Apr-2019 | A61K31/047 |
Eleison Pharmaceuticals Executive Team (8)
Eleison Pharmaceuticals Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000 | Self | Board Member | 000 0000 |
| 00000 0000000 | Capital Solutions | Board Member | 000 0000 |
| 0000 0000000000 00 | Self | Board Member | 000 0000 |
| 0000 0000000 | Self | Board Member | 000 0000 |
| 0000000 0000 00.0 | Self | Board Member | 000 0000 |
Eleison Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Eleison Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|